Recombinant Saccharomyces cerevisiae Triosephosphate isomerase (TPI1)

Shipped with Ice Packs
In Stock

Description

Recombinant Production Systems

TPI1 is expressed in S. cerevisiae using plasmid-based systems. Notable methods include:

  • POT1 plasmid system: Utilizes Schizosaccharomyces pombe POT1 as a selection marker, enabling high plasmid copy numbers under glucose selection .

  • Promoter engineering: The TEF1 and TPI1 promoters drive high-yield expression, with secretion signals (e.g., alpha-factor) enhancing extracellular production .

Table 2: Expression Systems for Recombinant TPI1

StrainPromoterSecretion SignalYield (Relative)
CEN.PK 530-1C (AIP)TEF1Alpha-factorHigh
CEN.PK 530-1C (SIP)TEF1YAP3-TA57Moderate

Germination Suppression

Recombinant TPI1 inhibits spore germination in S. cerevisiae by maintaining GAP levels. Key findings:

  • Mechanism: Catalytically active TPI1 converts glucose-derived metabolites to GAP, which suppresses germination at 10 μM .

  • Heat inactivation: Heating to 40°C (1 hour) or 95°C (15 seconds) abolishes enzymatic activity, triggering germination .

Oncogenic Role in Cancer

TPI1 exhibits non-glycolytic functions in lung adenocarcinoma (LUAD):

  • Nuclear translocation: Under stress, TPI1 relocates to the nucleus, promoting chemotherapy resistance and tumor growth independent of catalytic activity .

  • Clinical relevance: High TPI1 expression correlates with poor patient survival (HR = 1.84, p < 0.01) .

Key Mutants

MutantEffectCatalytic Activity
E104DReduced enzyme activity Partially impaired
E165ALoss of germination suppression Inactive

Biotechnological Implications

  • Industrial protein production: TPI1’s promoter and secretion systems are repurposed for high-yield recombinant protein synthesis (e.g., insulin precursors) .

  • Thermostable variants: Engineered TPI1 derivatives enable applications in high-temperature industrial processes .

Product Specs

Form
Lyophilized powder. We will ship the available format, but you can specify your preference when ordering.
Lead Time
Delivery times vary. Consult your local distributor for details. Proteins are shipped with blue ice packs. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. Specify your preferred tag type during ordering, and we will prioritize it if possible.
Synonyms
TPI1; YDR050C; YD9609.05C; Triosephosphate isomerase; TIM; EC 5.3.1.1; Triose-phosphate isomerase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
2-248
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
Target Names
Target Protein Sequence
ARTFFVGGN FKLNGSKQSI KEIVERLNTA SIPENVEVVI CPPATYLDYS VSLVKKPQVT VGAQNAYLKA SGAFTGENSV DQIKDVGAKW VILGHSERRS YFHEDDKFIA DKTKFALGQG VGVILCIGET LEEKKAGKTL DVVERQLNAV LEEVKDWTNV VVAYEPVWAI GTGLAATPED AQDIHASIRK FLASKLGDKA ASELRILYGG SANGSNAVTF KDKADVDGFL VGGASLKPEF VDIINSRN
Uniprot No.

Q&A

What is Triosephosphate Isomerase (TPI1) in Saccharomyces cerevisiae and why is it important for recombinant protein production?

Triosephosphate isomerase 1 (TPI1) is a key glycolytic enzyme in Saccharomyces cerevisiae that catalyzes the reversible interconversion of dihydroxyacetone phosphate (DHAP) to glyceraldehyde-3-phosphate (G3P). Beyond its metabolic function, the TPI1 promoter has gained significant attention in biotechnology due to its strong and constitutive expression characteristics. The TPI1 promoter is widely used for recombinant protein production because it can drive high gene expression across various glucose conditions . The promoter originates from the strongly expressed glycolytic gene TPI1 of S. cerevisiae and has become a standard tool for heterologous protein expression in yeast systems .

How does the TPI1 promoter compare to other common yeast promoters for recombinant protein expression?

The TPI1 promoter offers distinct advantages when compared to other commonly used yeast promoters:

PromoterExpression CharacteristicsAdvantagesLimitations
TPI1Strong constitutive expression tied to glycolytic pathwayConsistent expression in glucose media; reliable for stable protein productionMay cause metabolic burden during high expression
TEF1Strong constitutive expression independent of carbon sourceHigh expression in both high glucose and glucose-limited conditions Limited regulatory control
GAL1Strong inducible expressionPrecise control through galactose inductionRequires media changes; repressed by glucose
ADH1Moderate constitutive expressionLess metabolic burdenLower expression levels than TPI1
POT1-basedSelective pressure systemHigh plasmid stability even in rich medium Requires specific genetic backgrounds

The TPI1 promoter is often chosen when researchers need reliable, strong expression without the need for specific induction protocols. It has been successfully used in combination with various terminator sequences, such as the CYC1 terminator, to create efficient expression cassettes .

What are the fundamental methodological considerations when working with TPI1-based expression systems?

When utilizing TPI1-based expression systems, researchers should consider several key methodological aspects:

  • Vector Selection: Choose between integrative vs. episomal vectors based on expression stability requirements. POT1-based plasmids with TPI1 promoters offer high stability even in rich medium, which can generate higher cell numbers and protein yields .

  • Host Strain Optimization: Consider using strains with deletions in competing metabolic pathways. For instance, strains with mutations in the native genomic tpi gene do not grow on glucose, and complementation with a functional heterologous TPI can increase plasmid copy number to sustain rapid growth .

  • Expression Verification: Implement reliable quantification methods such as Western blotting and immunohistochemistry (IHC) to verify expression levels .

  • Cultivation Conditions: Optimize growth parameters including temperature, pH, and media composition to maximize protein production while maintaining cellular health.

  • Protein Purification Strategy: Design appropriate purification protocols considering the biochemical properties of both TPI1 and your target protein.

For successful implementation, researchers have developed specialized vectors like CPOTud, derived from POTud by replacing the TEF1 promoter and CYC1 terminator with the TPI1 promoter and terminator, respectively .

How do you design and construct a TPI1 promoter-based expression system for heterologous protein production?

Constructing a TPI1 promoter-based expression system requires a systematic approach:

  • Promoter Amplification: Amplify the TPI1 promoter (approximately 0.9 kb) from S. cerevisiae genomic DNA using PCR. For example, researchers have successfully used primers like sum006 and sum007 to amplify this region from YEplac181-P-TTPI1 .

  • Vector Backbone Selection: Choose an appropriate vector backbone with desired characteristics:

    • For high-copy expression: Use 2μm-based vectors with selection markers like HIS3 or TRP1

    • For stable expression: Consider POT1-based systems with the functional TPI copy to compensate for genomic tpi deletion

  • Cloning Strategy: Employ efficient cloning methods such as:

    • Restriction enzyme-based cloning (common sites include FseI, AscI, PstI)

    • Gateway recombinational cloning technology (as demonstrated for other genes)

    • Gibson Assembly for seamless construction

  • Terminator Selection: Pair the TPI1 promoter with appropriate terminators:

    • CYC1 terminator (0.15 kb) for efficient transcription termination

    • TPI1 terminator for potentially improved expression of TPI1-related genes

  • Transformation: Transform the constructed expression vector into S. cerevisiae using standard protocols:

    • Lithium acetate transformation

    • Electroporation for higher efficiency

    • Selection on appropriate drop-out media

An example approach is demonstrated in the construction of expression vectors for Hansenula polymorpha FMD gene under the control of the S. cerevisiae TPI1 promoter, which yielded functional enzyme expression with measurable activity (0.1 ± 0.0 U mg−1 protein) .

What methods are most effective for measuring recombinant TPI1 expression and activity?

Several complementary methods can be employed to assess recombinant TPI1 expression and activity:

Protein Expression Analysis:

  • Western Blotting: Quantifies protein expression levels using specific antibodies against TPI1 or epitope tags .

  • Immunohistochemistry (IHC): Visualizes protein localization within cells or tissues .

  • Mass Spectrometry: Provides precise identification and quantification of the expressed protein.

Enzyme Activity Assays:

  • Spectrophotometric Assays: Measures TPI1 activity by coupling to NAD(P)H-dependent reactions:

    • Forward reaction: DHAP → G3P (coupled with glyceraldehyde-3-phosphate dehydrogenase)

    • Reverse reaction: G3P → DHAP (coupled with glycerol-3-phosphate dehydrogenase)

  • Metabolite Analysis: Quantifies substrate utilization or product formation:

    • HPLC analysis of phosphorylated intermediates

    • LC-MS/MS for precise metabolite quantification

Functional Assays:

  • Growth Complementation: Tests functionality by complementing TPI1-deficient strains.

  • Stress Response Tests: Evaluates the impact of TPI1 expression on cellular resistance to various stressors.

For example, researchers measured formaldehyde dehydrogenase (Fld) activity in cell extracts of strains expressing H. polymorpha FLD1, finding activities of 4.5 ± 0.1 U mg−1 protein compared to 0.1 ± 0.0 U mg−1 protein in control strains .

How can TPI1 promoter strength be modulated for optimized heterologous protein expression?

Modulating TPI1 promoter strength can be achieved through several methodological approaches:

  • Promoter Engineering:

    • Truncation analysis to identify minimal functional regions

    • Site-directed mutagenesis of transcription factor binding sites

    • Creation of synthetic variants with modified regulatory elements

    • Development of hybrid promoters combining TPI1 elements with other regulatory sequences

  • Transcription Factor Modulation:

    • Overexpression of transcriptional activators that bind the TPI1 promoter

    • Deletion or inhibition of repressors that regulate TPI1 expression

    • Engineering of synthetic transcription factors with tunable activity

  • Environmental Condition Optimization:

    • Adjustment of glucose concentration to influence glycolytic flux

    • Modification of growth parameters (temperature, pH, oxygen levels)

    • Implementation of fed-batch strategies to maintain optimal expression conditions

  • Vector Copy Number Control:

    • Selection of different origins of replication (e.g., 2μm vs. CEN/ARS)

    • Employment of POT1-based systems where plasmid copy number increases to sustain rapid growth on glucose when the native genomic tpi gene is deleted

    • Integration of multiple expression cassettes into the genome

  • Codon Optimization:

    • Adaptation of the coding sequence to match S. cerevisiae codon bias

    • Removal of rare codons that might limit translation efficiency

    • Elimination of unintended regulatory elements in the coding sequence

This multi-faceted approach allows researchers to fine-tune expression levels according to specific experimental requirements and protein characteristics.

How can TPI1-based expression systems be integrated with metabolic engineering strategies?

Integration of TPI1-based expression systems with metabolic engineering strategies offers powerful approaches for advanced biocatalysis and synthetic metabolism:

  • Enzyme Cascade Engineering:

    • TPI1 promoters can drive expression of multiple enzymes in synthetic pathways

    • The strength of the TPI1 promoter enables sufficient enzyme production for effective metabolic flux

    • Example: Expression of formaldehyde dehydrogenase (FLD1) and formate dehydrogenase (FMD) from Hansenula polymorpha using TPI1 and TDH3 promoters enabled S. cerevisiae to coutilize formaldehyde with glucose, resulting in enhanced biomass yield

  • Redox Balance Optimization:

    • TPI1-driven expression of NADH-generating enzymes can enhance ATP production via oxidative phosphorylation

    • This approach can increase biomass yield on electron pair basis, as demonstrated with formaldehyde utilization

    • Strategic expression of enzymes with different cofactor specificities can rebalance NAD(P)H/NAD(P)+ ratios

  • Substrate Utilization Engineering:

    • TPI1 promoter strength enables sufficient expression of heterologous enzymes for alternative substrate utilization

    • Engineered strains expressing FLD1 under TDH3 promoter showed increased formaldehyde resistance (up to 30 mM) compared to control strains (up to 2 mM)

    • This resistance exceeded even native formaldehyde-metabolizing enzyme SFA1 overexpression (15-20 mM tolerance)

  • Pathway Compartmentalization:

    • TPI1-based expression can be targeted to specific cellular compartments through fusion with localization signals

    • This enables spatial organization of metabolic pathways for improved efficiency

    • Compartmentalization can reduce unwanted side reactions and intermediate loss

  • Dynamic Pathway Regulation:

    • Modified TPI1 promoters can be engineered to respond to metabolic signals

    • This creates self-regulating expression systems that adjust to cellular conditions

    • Integration with cellular stress responses can maintain productivity under changing environments

What are the known genetic and physical interactions of TPI1 in S. cerevisiae, and how do they impact experimental design?

Understanding the TPI1 interactome is crucial for experimental design in recombinant expression systems:

Genetic Interactions:
While specific genetic interactions of TPI1 aren't detailed in the search results, studies of other proteins like Hrq1 demonstrate how comprehensive genetic interaction analysis can be performed. Similar approaches could reveal TPI1's genetic network:

  • Synthetic Genetic Array (SGA) Analysis:

    • Could identify genes that synthetically interact with TPI1 mutations

    • Would potentially reveal connections to processes like DNA repair, chromosome segregation, and transcription

    • Such analysis would help predict potential system-wide effects of TPI1 manipulation

  • Suppressor/Enhancer Screens:

    • Could identify mutations that rescue or exacerbate TPI1 mutant phenotypes

    • May reveal unexpected functional connections between TPI1 and other cellular processes

Physical Interactions:
TPI1 likely engages in various protein-protein interactions that affect its function and regulation:

  • Metabolic Enzyme Complexes:

    • TPI1 may interact with other glycolytic enzymes in multi-enzyme complexes

    • These interactions could influence metabolic flux and enzyme efficiency

  • Regulatory Interactions:

    • TPI1 could interact with transcription factors or regulatory proteins

    • These interactions may be relevant for understanding feedback regulation

  • Non-canonical Interactions:

    • Evidence suggests TPI1 may interact with proteins outside of glycolysis

    • For example, TPI1 has been implicated in PI3K/AKT/mTOR signaling pathway activation

    • Such non-metabolic functions could impact experimental outcomes in unexpected ways

Experimental Design Implications:
Understanding these interactions informs several experimental considerations:

  • Control Selection: Include appropriate genetic backgrounds when manipulating TPI1

  • Phenotypic Analysis: Monitor not just target protein expression but also potential off-target effects

  • System Optimization: Engineer strains to minimize unwanted interactions or enhance beneficial ones

  • Data Interpretation: Consider broader cellular context when analyzing expression results

What are the most recent advancements in understanding TPI1 regulation under stress conditions?

Recent research has expanded our understanding of TPI1 regulation under various stress conditions, which has important implications for recombinant protein production:

  • Oxidative Stress Response:

    • TPI1 may undergo post-translational modifications during oxidative stress

    • These modifications can alter enzyme activity and stability

    • Expression systems utilizing the TPI1 promoter may show altered regulation under oxidative conditions

  • Nutrient Limitation Adaptation:

    • Studies show that formaldehyde utilization by engineered S. cerevisiae strains can be affected by nutrient limitations

    • Transcriptome analyses revealed that formaldehyde in the feed caused biotin limitations, preventing cultures from reaching steady-state conditions

    • This was resolved by using separate formaldehyde and vitamin feeds, enabling stable glucose-formaldehyde co-utilization

  • Metabolic Flux Redistribution:

    • TPI1 expression and activity may be modulated to redirect carbon flux under stress

    • Engineering the TPI1 promoter could enable dynamic response to changing metabolic conditions

    • This principle has been applied in systems where co-utilization of formaldehyde resulted in enhanced biomass yield under glucose-limited conditions

  • Gene Expression Networks:

    • Transcriptomic studies have shown that TPI1 expression correlates with changes in hundreds of genes

    • This suggests TPI1 is embedded in complex regulatory networks responding to environmental changes

    • Understanding these networks is crucial for predicting expression system behavior under stress

  • Protein Stability Regulation:

    • Degradation pathways may regulate TPI1 levels under stress

    • Evidence from other systems suggests that proteins like p62 can promote ubiquitin-dependent proteasome degradation of certain enzymes

    • Similar mechanisms might affect TPI1 and influence recombinant protein production systems

These advancements highlight the importance of considering stress responses when designing TPI1-based expression systems, particularly for applications requiring cultivation under suboptimal conditions.

What are the common challenges in achieving high-level expression with TPI1 promoter systems and how can they be addressed?

Researchers frequently encounter several challenges when using TPI1 promoter-based expression systems. Here are the most common issues and methodological approaches to address them:

  • Metabolic Burden and Growth Inhibition:

    • Challenge: Strong constitutive expression from the TPI1 promoter can redirect cellular resources away from growth

    • Solution: Implement fed-batch cultivation strategies to balance growth and expression; consider using inducible variants of the TPI1 promoter; optimize media composition to support both growth and protein production

  • Plasmid Stability Issues:

    • Challenge: Loss of expression plasmids during prolonged cultivation

    • Solution: Utilize POT1-based plasmid systems which demonstrate high plasmid stability even in rich medium ; consider genomic integration for long-term stability; maintain selective pressure throughout cultivation

  • Protein Misfolding and Aggregation:

    • Challenge: High expression rates can overwhelm cellular folding machinery

    • Solution: Co-express chaperones; lower cultivation temperature; optimize codon usage to modulate translation rate; fuse target proteins with solubility enhancers

  • Post-translational Modifications:

    • Challenge: Incorrect or insufficient modifications of target proteins

    • Solution: Engineer expression strains with enhanced modification capabilities; modify cultivation conditions to optimize post-translational processing

  • Protein Degradation:

    • Challenge: Proteolytic degradation of recombinant proteins

    • Solution: Use protease-deficient host strains; add protease inhibitors during extraction; optimize extraction conditions; design fusion proteins resistant to degradation

  • Biotin Limitation:

    • Challenge: Unexpected nutrient limitations affecting expression or function

    • Solution: Implement separate nutrient feeding strategies as demonstrated in formaldehyde utilization studies ; supplement media with additional vitamins and cofactors

  • Unpredictable Interactions with Native Metabolism:

    • Challenge: Interference between recombinant pathways and native metabolism

    • Solution: Perform transcriptomic analysis to identify unexpected interactions; engineer strains with reduced competing pathways; compartmentalize recombinant pathways

How can protein folding and solubility issues be addressed when expressing complex proteins under the TPI1 promoter?

Expressing complex proteins under the strong TPI1 promoter can lead to folding challenges and insolubility. Here are methodological approaches to enhance proper folding and solubility:

  • Translation Rate Modulation:

    • Methodology: Adjust codon usage in the target gene to control translation speed

    • Rationale: Slower translation at critical regions allows time for domain folding

    • Implementation: Identify structurally complex regions and introduce rare codons strategically

  • Chaperone Co-expression Strategies:

    • Methodology: Co-express molecular chaperones under regulated promoters

    • Rationale: Chaperones assist in proper protein folding and prevent aggregation

    • Implementation: Create dual plasmid systems with TPI1-driven target protein and chaperones (e.g., Hsp70, Hsp90, or GroEL/ES homologs)

  • Fusion Partner Approaches:

    • Methodology: Express target proteins as fusions with highly soluble partners

    • Rationale: Solubility tags can enhance folding and prevent aggregation

    • Implementation: Common fusion partners include thioredoxin, SUMO, MBP, or GST with engineered protease cleavage sites

  • Cultivation Condition Optimization:

    • Methodology: Adjust temperature, pH, and media composition

    • Rationale: Lower temperatures slow folding, allowing more time for correct conformations

    • Implementation: Reduced cultivation temperature (20-25°C) after induction; supplement media with folding aids like glycerol or arginine

  • Protein Engineering Approaches:

    • Methodology: Introduce mutations that enhance stability without affecting function

    • Rationale: Strategic mutations can improve folding efficiency and reduce aggregation

    • Implementation: Use computational prediction tools to identify stabilizing mutations; remove hydrophobic patches or introduce disulfide bonds

  • Secretion-Based Expression:

    • Methodology: Direct proteins to the secretory pathway

    • Rationale: The ER provides specialized folding environment with quality control

    • Implementation: Fuse appropriate signal sequences; utilize TPI1 to drive strong expression through the secretory pathway

  • In vitro Refolding Strategies:

    • Methodology: Recover protein from inclusion bodies followed by controlled refolding

    • Rationale: Sometimes higher yields can be achieved by refolding from insoluble material

    • Implementation: Establish efficient solubilization and step-wise refolding protocols

These approaches can be applied individually or in combination depending on the specific properties of the target protein.

How are systems biology approaches enhancing our understanding of TPI1 function and regulation in yeast?

Systems biology approaches are revolutionizing our understanding of TPI1 in yeast through integrated multi-omics investigations:

  • Interactome Mapping:

    • Methodology: Systematic protein-protein interaction studies using techniques such as co-immunoprecipitation (Co-IP) followed by mass spectrometry

    • Applications: Reveals both expected metabolic interactions and unexpected non-canonical partners

    • Impact: Similar approaches with other proteins have identified connections to processes like DNA repair, chromosome segregation, and transcription

  • Transcriptomic Analysis:

    • Methodology: RNA-seq and microarray analysis under various conditions

    • Applications: Identifies genes co-regulated with TPI1 and affected by TPI1 manipulation

    • Impact: Studies of related systems show that hundreds of genes can be affected by the mutation of a single metabolic gene

  • Metabolic Flux Analysis:

    • Methodology: 13C-labeled substrate tracing combined with mass spectrometry

    • Applications: Quantifies how TPI1 expression levels affect carbon distribution

    • Impact: This approach has demonstrated how engineered strains can effectively utilize alternative substrates like formaldehyde

  • Computational Modeling:

    • Methodology: Genome-scale metabolic models incorporating enzymatic parameters

    • Applications: Predicts metabolic outcomes of TPI1 manipulation

    • Impact: Enables rational design of expression systems with optimal metabolic configurations

  • Synthetic Genetic Array Analysis:

    • Methodology: Systematic creation and phenotyping of double mutants

    • Applications: Identifies genetic interactions that reveal functional relationships

    • Impact: Similar approaches with other genes have identified synthetic interactions relevant to understanding gene function

  • Multi-omics Integration:

    • Methodology: Combined analysis of genomic, transcriptomic, proteomic, and metabolomic data

    • Applications: Provides comprehensive understanding of TPI1's role in cellular homeostasis

    • Impact: Reveals emergent properties not apparent from single-omics approaches

These systems approaches are creating a more holistic understanding of TPI1 beyond its canonical glycolytic role, informing better designs for recombinant expression systems.

What non-metabolic functions of TPI1 have been discovered, and how might they impact recombinant expression systems?

Recent research has uncovered intriguing non-metabolic functions of TPI1 that extend beyond its classical role in glycolysis, with potential implications for recombinant expression systems:

These non-canonical functions highlight the importance of considering TPI1 in a broader cellular context when designing recombinant expression systems. Researchers might need to account for these roles when interpreting experimental results, particularly when observing unexpected phenotypes in TPI1-based expression systems.

How might CRISPR-based technologies revolutionize TPI1 promoter engineering for recombinant protein production?

CRISPR-based technologies are poised to transform TPI1 promoter engineering for recombinant protein production through unprecedented precision and efficiency:

  • Base Editing of Regulatory Elements:

    • Methodology: CRISPR base editors to precisely modify specific nucleotides within the TPI1 promoter

    • Applications: Fine-tune promoter strength by altering transcription factor binding sites

    • Advantage: Creates subtle modifications without introducing double-strand breaks, reducing unwanted mutations

  • Multiplexed Promoter Variant Libraries:

    • Methodology: CRISPR array-based approaches to generate thousands of TPI1 promoter variants simultaneously

    • Applications: High-throughput screening for optimal expression characteristics

    • Advantage: Accelerates identification of context-specific optimal promoter variants

  • Epigenetic Regulation:

    • Methodology: CRISPR-based epigenome editors (dCas9 fused to epigenetic modifiers)

    • Applications: Reversible modulation of TPI1 promoter activity without genetic modification

    • Advantage: Allows dynamic control of expression without permanent genetic changes

  • Synthetic Transcription Factor Engineering:

    • Methodology: dCas9 fused to activator or repressor domains targeting TPI1 promoter regions

    • Applications: Programmable regulation of TPI1-driven expression

    • Advantage: Enables inducible control of otherwise constitutive TPI1 promoter

  • Genomic Integration Precision:

    • Methodology: CRISPR-mediated targeted integration of TPI1 expression cassettes

    • Applications: Position expression constructs at optimal genomic locations

    • Advantage: Avoids position effects that can influence expression variability

  • Promoter Architecture Redesign:

    • Methodology: CRISPR-facilitated promoter element shuffling and synthetic design

    • Applications: Create hybrid promoters combining TPI1 elements with components from other promoters

    • Advantage: Generates novel regulatory properties not found in natural promoters

  • Conditional Expression Systems:

    • Methodology: CRISPR-engineered TPI1 promoters containing regulated elements

    • Applications: Dynamic response to specific metabolic states or external inducers

    • Advantage: Combines TPI1's strength with on-demand expression control

These CRISPR-enabled approaches could generate precisely tailored TPI1-based expression systems with unprecedented control over expression timing, magnitude, and response to environmental conditions, ultimately enhancing the versatility and productivity of recombinant protein production in yeast.

How does the performance of TPI1-based expression systems compare across different yeast species?

TPI1-based expression systems show notable variations across different yeast species, reflecting their evolutionary divergence and metabolic adaptations:

Yeast SpeciesTPI1 Promoter CharacteristicsExpression PerformanceUnique AdvantagesLimitations
Saccharomyces cerevisiaeStrong constitutive expression tied to glycolysisHigh protein yields in glucose mediaWell-characterized; extensive genetic tools; Generally Recognized As Safe (GRAS) statusLimited post-translational modifications; potential metabolic burden
Schizosaccharomyces pombeRegulated differently than S. cerevisiaeModerate expression levelsPOT1 gene (TPI homolog) used as selection marker in S. cerevisiae systems Fewer genetic tools than S. cerevisiae
Pichia pastoris (Komagataella phaffii)Methanol-inducible variation availableHigh secretion capacityExcellent for secreted proteins; high cell densitiesDifferent optimal codon usage than S. cerevisiae
Hansenula polymorpha (Ogataea polymorpha)Thermotolerant characteristicsStable at higher temperaturesSource of heterologous genes like FLD1 and FMD expressed under S. cerevisiae TPI1 promoter Less commonly used expression system
Kluyveromyces lactisLess glucose repressionGalactose-independent expressionEfficient secretion; GRAS statusLower transformation efficiency

This comparative analysis demonstrates that while the basic glycolytic function of TPI1 is conserved across yeast species, regulatory elements and expression characteristics vary significantly. These differences can be exploited for specialized applications, such as using the POT1 gene from S. pombe in S. cerevisiae expression systems to enhance plasmid stability , or expressing H. polymorpha genes under the control of S. cerevisiae promoters like TPI1 to enable new metabolic capabilities .

The choice of species should be guided by specific project requirements, including protein complexity, required modifications, cultivation conditions, and regulatory considerations.

What are the advantages and limitations of TPI1 promoter compared to inducible promoter systems for different research applications?

TPI1 promoter systems offer distinct advantages and limitations compared to inducible promoter systems, making each suitable for different research applications:

AspectTPI1 Promoter (Constitutive)Inducible Promoter SystemsBest Applications
Expression ControlContinuous expression throughout growth; limited controlPrecise temporal control; tunable expression levelsTPI1: Continuous protein production
Inducible: Toxic protein expression; metabolic studies
Experimental SimplicityNo induction step required; simplified protocolsRequires addition of inducer; monitoring of induction timingTPI1: High-throughput screening; routine expression
Inducible: Mechanistic studies requiring precise timing
Growth ImpactPotential metabolic burden throughout growthBurden restricted to post-induction phaseTPI1: Stable, non-toxic proteins
Inducible: Growth-inhibiting proteins
Expression ConsistencyRelatively consistent between cellsPotential variation in induction efficiencyTPI1: Applications requiring population homogeneity
Inducible: Studies accepting cell-to-cell variation
Metabolic ContextExpression linked to glycolytic activityExpression independent of central metabolism (depending on inducer)TPI1: Metabolic engineering of glycolysis-related pathways
Inducible: Orthogonal metabolic engineering
Scale-up ConsiderationsSimplified scale-up; no induction phaseInduction may be challenging in large vesselsTPI1: Industrial production
Inducible: Laboratory-scale studies
Nutrient RequirementsStandard media sufficientMay require specific inducers (e.g., galactose, methanol)TPI1: Minimal media applications
Inducible: Applications where inducer cost is acceptable

Research examples demonstrate these tradeoffs: The TPI1 promoter has been successfully used for strong expression of genes like H. polymorpha FMD, achieving measurable enzyme activity (0.1 ± 0.0 U mg−1 protein) without induction steps . Meanwhile, inducible systems offer advantages when temporal control is critical, such as when expressing proteins that might interfere with cell growth or when studying dynamic processes.

How do different terminators pair with the TPI1 promoter to affect recombinant protein expression levels?

The choice of terminator sequences paired with the TPI1 promoter significantly impacts recombinant protein expression through multiple mechanisms:

TerminatorKey CharacteristicsEffect on ExpressionOptimal ApplicationsResearch Evidence
CYC1 terminatorShort (~150 bp); efficient terminationModerate expression level; well-defined 3' endGeneral expression applications; constructs with size constraintsUsed in combination with TPI1 promoter in vector construction; researchers amplified a 0.15-kb fragment containing CYC1 terminator from pESC-TRP using specific primers
TPI1 terminatorNative pairing with TPI1 promoterOften higher expression; potentially improved mRNA stabilityHigh-level expression; cases where native context is beneficialTPI1 promoter and terminator were purified from genomic DNA of S. cerevisiae using specific primers and ligated together after digestion with NheI
ADH1 terminatorStrong termination signalEnhanced mRNA stability; potentially higher protein yieldsApplications requiring maximum expressionLess commonly paired with TPI1 in literature but used in standard expression vectors
PGK1 terminatorEfficient processingConsistent expression level; good mRNA stabilityApplications requiring reliable expressionUsed in commercial expression vectors
TDH3 terminatorDerived from another strong glycolytic genePotentially synergistic with TPI1 promoterMetabolic pathway engineeringLess frequently documented with TPI1 promoter

Experimental evidence shows that terminator choice affects not just expression level but also other characteristics:

  • mRNA Stability: Different terminators confer varying degrees of protection against mRNA degradation

  • 3' End Processing: Terminator efficiency influences correct transcript processing

  • Expression Consistency: Some terminator-promoter pairs produce more consistent expression across conditions

  • Construct Compatibility: CPOTud plasmid was derived from POTud by replacing the TEF1 promoter and CYC1 terminator with the TPI1 promoter and terminator

The optimal promoter-terminator combination should be determined empirically for each specific application, as the interplay between these elements can be context-dependent.

What emerging technologies might enhance the utility of TPI1-based expression systems in the next decade?

Several cutting-edge technologies are poised to revolutionize TPI1-based expression systems in the coming decade:

  • Synthetic Genomics and Whole-Genome Engineering:

    • Synthetic minimal yeast genomes with optimized TPI1 expression contexts

    • Genome-wide codon optimization to support TPI1-driven high-level expression

    • Implementation of orthogonal genetic codes to enhance protein production

  • AI-Driven Promoter Design:

    • Machine learning algorithms to predict optimal TPI1 promoter variants for specific applications

    • Neural networks trained on expression data to design synthetic TPI1-derived promoters with desired characteristics

    • Automated design-build-test-learn pipelines for rapid promoter optimization

  • Single-Cell Analysis Technologies:

    • Microfluidic systems for real-time monitoring of TPI1-driven expression at single-cell resolution

    • Cell sorting based on expression profiles to isolate optimal producer cells

    • Single-cell omics to understand cell-to-cell variability in TPI1-based systems

  • In Vivo Biosensors for Expression Monitoring:

    • Real-time sensors for TPI1 promoter activity

    • Metabolic state monitors to correlate glycolytic flux with expression levels

    • Feedback-controlled expression systems responding to product accumulation

  • Advanced Bioprocess Technologies:

    • Continuous bioprocessing systems optimized for TPI1-based expression

    • Integrated bioreactor systems with real-time adjustment of conditions based on expression monitoring

    • 3D-printed customized bioreactors designed for specific TPI1 expression applications

  • Extracellular Vesicle Production Platforms:

    • TPI1-driven loading of therapeutic proteins into yeast extracellular vesicles

    • Engineered vesicle secretion systems for simplified downstream processing

    • Non-lytic protein harvesting strategies to maintain continuous production

  • Synthetic Cellular Compartments:

    • Engineered organelles for sequestering TPI1-driven expression products

    • Liquid-liquid phase separation domains for enhanced protein production

    • Spatial organization of TPI1-expressed enzymes for improved metabolic channeling

These technologies will likely transform TPI1-based expression from a standard laboratory tool into a sophisticated, precisely controllable platform for advanced biological manufacturing and research applications.

How might understanding the evolution of TPI1 across species inform better expression system design?

Evolutionary insights into TPI1 can significantly inform the design of next-generation expression systems:

  • Promoter Architecture Optimization:

    • Evolutionary Analysis: Comparative genomics of TPI1 promoters across yeast species reveals conserved regulatory elements

    • Design Application: Identify critical functional elements for synthetic promoter construction

    • Research Potential: Creation of hybrid promoters incorporating conserved elements from TPI1 promoters of multiple species

  • Thermostability Enhancement:

    • Evolutionary Analysis: TPI1 from thermophilic yeasts contains adaptations for stability at high temperatures

    • Design Application: Incorporate thermostable elements into expression hosts for high-temperature bioprocesses

    • Research Potential: Expression systems functional across broader temperature ranges, reducing cooling requirements

  • Metabolic Context Adaptation:

    • Evolutionary Analysis: Different yeast species have evolved TPI1 regulation matched to their metabolic lifestyles

    • Design Application: Select regulatory elements from species with metabolic patterns matching desired production conditions

    • Research Potential: TPI1 promoters from Crabtree-negative yeasts could offer advantages for certain bioprocesses

  • Protein-Protein Interaction Networks:

    • Evolutionary Analysis: Conservation analysis of TPI1 interaction surfaces across species

    • Design Application: Engineer expression hosts to optimize or minimize specific interactions

    • Research Potential: Reduced interference with host metabolism through modification of conserved interaction sites

  • Codon Usage Patterns:

    • Evolutionary Analysis: Species-specific adaptive codon bias in TPI1 genes

    • Design Application: Optimize heterologous gene codon usage based on highly expressed native genes like TPI1

    • Research Potential: Expression vectors with codon optimization patterns informed by evolutionary patterns

  • Cross-Species Functional Elements:

    • Evolutionary Analysis: Functional complementation tests using TPI1 genes from diverse species (like POT1 from S. pombe in S. cerevisiae )

    • Design Application: Identify superior functional elements regardless of evolutionary distance

    • Research Potential: Systems leveraging advantageous properties from phylogenetically diverse TPI1 genes

This evolutionary approach has already demonstrated value, as seen in the successful use of the POT1 gene from S. pombe in S. cerevisiae expression systems, where the heterologous TPI complemented the function of the native gene while offering improved plasmid stability .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.